-200% 0 -1,789 -100% EPS (Baht/share) -0.02 -1.81 -99% 0.02 -200% 0.00 -1.75 -100% Note : (1) Adjusted EBITDA refers to EBITDA excluding impact of Stock Gain/(Loss) and NRV (2) Extra items were expenses
lower stock loss. As aforementioned, the company realized net profit of THB 22 million, a decrease of 66% compare to 1Q2018. As of 31 March 2019, the company has total assets in the amount of THB 12,799
โทร 02 118 9599 โทรสาร 02 118 9598 ทะเบยีนเลขที ่0107554000232 No.: PACE-L 27/2019 Date: 8 November 2019 Subject: Disposal of shares in the subsidiary (Additional) To: President Stock Exchange of
subscribers at the price of Baht 3.90 per share (0.50 Baht for paid up capital and 3.40 Baht for share premium) total of 312 Million Baht. And the shares of the Company began trading in the Stock Exchange of
' Issue TCR /*' % Local Clearing Agency "( ' %A( TCR TCR Investor Local Broker Local Stock Exchange 1: TCR Foreign Broker 2: Underlying %&' ( Foreign Stock Exchange Underlying Foreign
Palmer & Turner (Thailand) Ltd MJD.IR.003/2561 28 February 2018 Subject : Clarification of the operating result for the year 2017 ended December 31, 2017 To : Director and Manager The Stock Exchange
10th May, 2018 Subject: Management Discussion and Analysis (MD&A) of the financial as at and for three months’ period ending 31st March, 2018 Attention: President The Stock Exchange of Thailand P.C.S
Microsoft Word - MD&A Y2018-E.doc 1 Ref: CSO. 003/2019 Date: 20th February 2019 Subject: Management Discussion and Analysis for Year Ending 31st December 2018 Attention: President The Stock Exchange
. DOD2019/004 February 20, 2019 Subject: Management’s discussion and analysis of the Company’s operating results for the year 2018 period To: President The Stock Exchange of Thailand DOD Biotech Public